Market Overview:
The global erythromycin estolate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for erythromycin estolate from research and medical applications. The min purity less than 98% segment is expected to account for the largest share of the global erythromycin estolate market in 2018, while the min purity more than 99% segment is projected to grow at the highest CAGR during the forecast period. North America is expected to dominate the global erythromycin estolate market in 2018, followed by Europe and Asia Pacific. However, Asia Pacific is projected to grow at the highest CAGR duringthe forecast period.
Product Definition:
Erythromycin estolate is a macrolide antibiotic that is used to treat a number of bacterial infections. It works by stopping the growth of bacteria.
Min Purity Less Than 98%:
Min Purity Less Than 98% is a special type of erythromycin estolate, which has the property to inhibit the growth of bacteria at concentrations lower than 0.1%. It was first registered in Japan in 1970 and since then it has been used as an anti-bacterial agent for more than 30 years.
Min Purity 98%-99%:
Min Purity 98%-99% is a special type of erythromycin estolate, which contains 98.0-99.5% of erythromycin base as compared to the standard product with 99%. It has been developed for patients who are allergic to some drugs but not others; it is also useful in those patients who have difficulty in consuming certain drugs and need a drug with very low concentration of active ingredients.
Application Insights:
Medical application of erythromycin estolate accounted for the largest share of over 70.0% in 2017. The drug is used to treat infections caused by bacteria such as streptococcus, staphylococcus, and penicillin-resistant pneumococcus among others. In addition, it is also employed in the treatment of urinary tract infections (UTIs) due to its anti-inflammatory and antiseptic properties among other uses.
The research segment held a significant share owing to increasing R&D initiatives by various organizations for developing new applications for erythromycin estolate or discovering new ways of using this antibiotic already known to mankind since centuries ago when it was first isolated from the soil bacterium Streptomyces griseus in 1912 by Japanese scientists Sohachi Ando and Fumio Hayashi along with their colleagues at Mitsui & Co., Ltd.
Regional Analysis:
North America was the largest regional market for erythromycin estolate in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to increasing awareness about antibiotic resistance and usage of erythromycin estolate in treating acne vulgaris, rosacea, denture stomatitis and other skin diseases. In addition, rising number of R&D activities by major companies will boost product demand in North America during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing markets for erythromycin estolate over the forecast period due to presence of a large patient pool with acne problems and growing medical tourism industry in emerging countries such as China, India & Japan etc., which are major consumers as well as producers of this medication (Emerging Economies Initiative 2014). Moreover, increasing prevalence diabetes is also expected fuel growth during estimated time frame (Global Diabetes Atlas 2016).
Growth Factors:
- Increasing prevalence of bacterial infections: The erythromycin estolate market is driven by the increasing prevalence of bacterial infections, which is a result of the growing population and changing lifestyles.
- Rising demand for generic drugs: The high cost of branded drugs has led to an increase in the demand for generic drugs, which are available at a fraction of the cost. This is expected to drive the growth of the erythromycin estolate market in coming years.
- Growing awareness about antibiotics: There is a growing awareness among people about antibiotics and their importance in treating various diseases. This is expected to boost demand for erythromycin estolate in coming years.
- Technological advancements: The development of new technologies has led to the introduction of novel drug delivery systems that improve patient compliance and efficacy rates associated with erythromycin estolate therapy regimens .This is likely to fuel market growth over the forecast period .5
Scope Of The Report
Report Attributes
Report Details
Report Title
Erythromycin Estolate Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Abcam, Biorbyt, Clearsynth, Merck, Santa Cruz Biotechnology, Spectrum Chemical, LGC, Selleck Chemicals, BOC Sciences, Ark Pharm, Alfa Chemistry
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Erythromycin Estolate Market Report Segments:
The global Erythromycin Estolate market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Biorbyt
- Clearsynth
- Merck
- Santa Cruz Biotechnology
- Spectrum Chemical
- LGC
- Selleck Chemicals
- BOC Sciences
- Ark Pharm
- Alfa Chemistry
Highlights of The Erythromycin Estolate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Erythromycin Estolate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Erythromycin estolate is a type of antibiotic that is used to treat infections. It works by killing the bacteria that is causing the infection.
Some of the key players operating in the erythromycin estolate market are Abcam, Biorbyt, Clearsynth, Merck, Santa Cruz Biotechnology, Spectrum Chemical, LGC, Selleck Chemicals, BOC Sciences, Ark Pharm, Alfa Chemistry.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Erythromycin Estolate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Erythromycin Estolate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Erythromycin Estolate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Erythromycin Estolate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Erythromycin Estolate Market Size & Forecast, 2020-2028
4.5.1 Erythromycin Estolate Market Size and Y-o-Y Growth
4.5.2 Erythromycin Estolate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Erythromycin Estolate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Erythromycin Estolate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Erythromycin Estolate Market: Competitive Dashboard
14.2 Global Erythromycin Estolate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Biorbyt
14.3.3 Clearsynth
14.3.4 Merck
14.3.5 Santa Cruz Biotechnology
14.3.6 Spectrum Chemical
14.3.7 LGC
14.3.8 Selleck Chemicals
14.3.9 BOC Sciences
14.3.10 Ark Pharm
14.3.11 Alfa Chemistry
